Trial Profile
A Study to Survey the Swallowability of Uncoated 200-mg Tablets of Etravirine in HIV-1 Infected Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Dec 2012
Price :
$35
*
At a glance
- Drugs Etravirine (Primary) ; Etravirine
- Indications HIV-1 infections
- Focus Therapeutic Use
- Sponsors Janssen R&D Ireland
- 22 Jul 2010 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
- 22 Jul 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 May 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.